A look at some of the exciting drugs that could be approved in the coming months.
Scott Gottlieb’s tenure at the FDA was marked by hundreds of generic approvals and aggressive moves against the tobacco industry and vaping.
The annual report on generic access and savings shows some impressive numbers for 2017.
Standardization coming for drug labeling and packaging.
High drug prices are caused by a variety of forces—but pharmacists always seem to get caught in the crossfire.
Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.